Get started
Work

Phase I Trial of Dose-Escalated Five-Fraction Stereotactic Ablative Radiotherapy for Early-Stage Lung Squamous Cell Carcinoma

Year: 2021
Type: article
Study design: Clinical Trial
DOI: 10.1016/j.ijrobp.2021.07.1270
Authors: K. Shiue, A. Cerra-Franco, V. Verma, M. Arbab, M.P. Langer, C. Deig, M.E. Tharp II, P.A. Anthony, M. Shan, S. Althouse, Y. Zang, G.K. Bartlett, J.A. Holmes, C. DesRosiers, P.G. Maxim, D. Frye, F.M. Kong, J.Y. Jin, G. Watson, R.C. Zellars, T. Lautenschlaeger
Institutions: Indiana University School of Medicine, University of Nebraska Medical Center, Indiana University Indianapolis, Indiana University Health, Indiana University Hospital, Indiana University, Queen Mary Hospital, University of Hong Kong, University Hospitals of Cleveland, Case Western Reserve University
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3210190947
FWCI:
Cites:
Cited by:
Related to: 10